The Australian Dementia Network (ADNeT) - Trials screening program

Occurring Dates: 
31/12/2018 to 31/12/2020
Participant Duration: 
Up to 3 months
State of study: 
Victoria
Overview: 

This program is currently seeking patients with a diagnosis of Mild Cognitive Impairment or early Alzheimer's disease who are interested in joining a therapy (drug) trial. Patients are assessed to determine their likely eligibility for trials accepting new patients in Melbourne Victoria, and referred to these trials as appropriate.

Assessment in this program includes:

  • Review of medical history
  • Blood tests
  • Memory and thinking tests
  • Questionnaires
  • Brain scans (2 PET scans and 1 MRI)
Further Information: 

For further information, please contact Alex Barac on (03) 9389 2938, or Jo Robertson on (03) 9389 2937, or email ADNETscreening@florey.edu.au.

This project has been approved by the Austin Health Human Research Ethics Committee, approval number HREC/18/Austin/202.

Study Address: 
The Florey Institute of Neuroscience and Mental Health 30 Royal Parade Parkville VIC 3052
Full Name: 
Jo Robertson
Institute: 
The Florey Institute of Neuroscience and Mental Health
Email: 
joanner@unimelb.edu.au
Phone Number: 
(03) 9389 2937